澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

BIO-GENE TECHNOLOGY LTD

0.014

0.000

成交量：- -

成交额：- -

市值：613.29万

市盈率：-1.86

高：0.014

开：0.014

低：0.014

收：0.014

52周最高：0.049

52周最低：0.014

股本：4.38亿

流通股本：1.68亿

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.008

每股收益(LYR):-0.008

净资产收益率：-125.40%

总资产收益率：-61.86%

市净率：2.93

市盈率(LYR):-1.86

数据加载中...

总览公司新闻资讯公告

Bio-Gene Technology Ltd 通过配售及部分包销购股计划筹集321万澳元

Bio-Gene Technology将扩大Flavocide与Qcide病媒控制产品在亚洲的评估范围

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/BGT.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BGT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BGT.AU\",,,,,undefined,":{"symbol":"BGT.AU","market":"AU","secType":"STK","nameCN":"BIO-GENE TECHNOLOGY LTD","latestPrice":0.014,"timestamp":1791868320000,"preClose":0.014,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"BIO-GENE TECHNOLOGY LTD","floatShares":168118597,"shares":438061108,"eps":-0.00754,"marketStatus":"已收盘","change":0,"latestTime":"10-13 16:12:00 AEDT","open":0.014,"high":0.014,"low":0.014,"amount":0,"amplitude":0,"askPrice":0.015,"askSize":14288,"bidPrice":0.014,"bidSize":694003,"shortable":3,"etf":0,"ttmEps":-0.00754,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791932400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.014,"openAndCloseTimeList":[[1791846000000,1791867600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BGT.AU","preClose":0.014,"auctionPrice":0.014,"auctionVolume":203505,"auction":3,"marketStatus":"盘后竞价","timestamp":1791522000557}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BGT.AU\",,,,,undefined,":{"symbol":"BGT.AU","floatShares":168118597,"roa":"-61.86%","roe":"-125.40%","lyrEps":-0.00754,"shares":438061108,"dividePrice":0,"high":0.014,"amplitude":0,"preClose":0.014,"low":0.014,"week52Low":0.014,"pbRate":"2.93","psRate":"5.68","week52High":0.049,"institutionHeld":0,"latestPrice":0.014,"committee":0.959655,"eps":-0.00754,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.00754,"open":0.014,"prevYearClose":0.023,"prevWeekClose":0.014,"prevMonthClose":0.016,"prevQuarterClose":0.016,"fiveDayClose":0.016,"twentyDayClose":0.017,"sixtyDayClose":0.017},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BGT.AU\",params:#limit:5,,,undefined,":[{"date":"2023-04-27","symbol":"BGT.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1682553600000,"name":null,"time":"","dateTimestamp":1682517600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BGT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BGT.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1196205410","title":"Bio-Gene Technology Ltd 通过配售及部分包销购股计划筹集321万澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196205410","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196205410?lang=zh_cn&edition=fundamental","pubTime":"2026-05-26 09:24","pubTimestamp":1779758665,"startTime":"0","endTime":"0","summary":"Bio-Gene Technology Ltd成功通过配售及部分包销的股票购买计划，筹集了总额321万澳元的资金。此次融资活动以每股0.025澳元的价格进行，共获得271万澳元的毛收益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7020","BGT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111470522","title":"Bio-Gene Technology将扩大Flavocide与Qcide病媒控制产品在亚洲的评估范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1111470522","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111470522?lang=zh_cn&edition=fundamental","pubTime":"2026-05-21 09:43","pubTimestamp":1779327824,"startTime":"0","endTime":"0","summary":"Bio-Gene Technology Ltd宣布，将把其Flavocide与Qcide病媒控制产品的评估工作扩展至亚洲市场。此举标志着该公司在推广其创新病媒控制解决方案方面迈出了重要一步，旨在应对亚洲地区广泛的公共卫生挑战。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGT.AU","BK7020"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}